These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 22193418)

  • 1. Factors predicting Medicare national coverage: an empirical analysis.
    Chambers JD; Morris S; Neumann PJ; Buxton MJ
    Med Care; 2012 Mar; 50(3):249-56. PubMed ID: 22193418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does Medicare have an implicit cost-effectiveness threshold?
    Chambers JD; Neumann PJ; Buxton MJ
    Med Decis Making; 2010; 30(4):E14-27. PubMed ID: 20551473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medicare's national coverage determinations in diagnostic radiology: examining evidence and setting limits.
    Otero HJ; Chambers JD; Bresnahan BW; Kamae MS; Yucel KE; Neumann PJ
    Acad Radiol; 2012 Sep; 19(9):1060-5. PubMed ID: 22748382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medicare's national coverage decisions for technologies, 1999-2007.
    Neumann PJ; Kamae MS; Palmer JA
    Health Aff (Millwood); 2008; 27(6):1620-31. PubMed ID: 18997221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medicare's national coverage decisions, 1999-2003: quality of evidence and review times.
    Neumann PJ; Divi N; Beinfeld MT; Levine BS; Keenan PS; Halpern EF; Gazelle GS
    Health Aff (Millwood); 2005; 24(1):243-54. PubMed ID: 15647237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inadequate prescription-drug coverage for Medicare enrollees--a call to action.
    Soumerai SB; Ross-Degnan D
    N Engl J Med; 1999 Mar; 340(9):722-8. PubMed ID: 10053183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Illustrating potential efficiency gains from using cost-effectiveness evidence to reallocate Medicare expenditures.
    Chambers JD; Lord J; Cohen JT; Neumann PJ; Buxton MJ
    Value Health; 2013 Jun; 16(4):629-38. PubMed ID: 23796298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opacity and cost effectiveness analysis in Medicare coverage decisions: health policy encounters administrative law.
    Kolber MS
    Food Drug Law J; 2009; 64(3):515-30. PubMed ID: 19999645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PDP or MA-PD? Medicare part D enrollment decisions in CMS Region 25.
    Cline RR; Worley MM; Schondelmeyer SW; Schommer JC; Larson TA; Uden DL; Hadsall RS
    Res Social Adm Pharm; 2010 Jun; 6(2):130-42. PubMed ID: 20511112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variations between clinical trial participants and Medicare beneficiaries in evidence used for Medicare national coverage decisions.
    Dhruva SS; Redberg RF
    Arch Intern Med; 2008 Jan; 168(2):136-40. PubMed ID: 18227358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medicare is scrutinizing evidence more tightly for national coverage determinations.
    Chambers JD; Chenoweth M; Cangelosi MJ; Pyo J; Cohen JT; Neumann PJ
    Health Aff (Millwood); 2015 Feb; 34(2):253-60. PubMed ID: 25646105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Why Medicare has not established criteria for coverage decisions.
    Tunis SR
    N Engl J Med; 2004 May; 350(21):2196-8. PubMed ID: 15152066
    [No Abstract]   [Full Text] [Related]  

  • 13. Impact of cost sharing on prescription drugs used by Medicare beneficiaries.
    Goedken AM; Urmie JM; Farris KB; Doucette WR
    Res Social Adm Pharm; 2010 Jun; 6(2):100-9. PubMed ID: 20511109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Declassifying coverage. New guidance documents issued by the CMS may clarify the great unknown of Medicare coverage determination.
    Barr P
    Mod Healthc; 2005 Mar; 35(12):6-7, 1. PubMed ID: 15801288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health insurance and health at age 65: implications for medical care spending on new Medicare beneficiaries.
    Hadley J; Waidmann T
    Health Serv Res; 2006 Apr; 41(2):429-51. PubMed ID: 16584457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Care and trembling.
    Stone D
    Caring; 1999 Mar; 18(3):8-10, 12-4. PubMed ID: 10387567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medicare coverage for technological innovations.
    Hart S
    N Engl J Med; 2004 Aug; 351(7):719-20; author reply 719-20. PubMed ID: 15309749
    [No Abstract]   [Full Text] [Related]  

  • 18. CHANGING FACE OF MEDICARE'S NATIONAL COVERAGE DETERMINATIONS FOR TECHNOLOGY.
    Chambers JD; Chenoweth MD; Pyo J; Cangelosi MJ; Neumann PJ
    Int J Technol Assess Health Care; 2015 Jan; 31(5):347-54. PubMed ID: 26750558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does providing cost-effectiveness information change coverage priorities for citizens acting as social decision makers?
    Gold MR; Franks P; Siegelberg T; Sofaer S
    Health Policy; 2007 Sep; 83(1):65-72. PubMed ID: 17204347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reflections on science, judgment, and value in evidence-based decision making: a conversation with David Eddy by Sean R. Tunis.
    Eddy D
    Health Aff (Millwood); 2007; 26(4):w500-15. PubMed ID: 17580317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.